Reason: Crystallization: Formation of crystals observed in product.
Distributed: NationwideReason: Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.
Distributed: U.S. NationwideReason: Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.
Distributed: NationwideReason: Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Distributed: NationwideReason: Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.
Distributed: NationwideReason: Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense.
Distributed: NationwideReason: Defective Container: Product leaks when inverted.
Distributed: U.S. Nationwide, including Puerto RicoReason: Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol
Distributed: NationwideReason: Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.
Distributed: NationwideReason: Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.
Distributed: Nationwide